tiprankstipranks
RHON-KLINIKUM AG (GB:0NQH)
LSE:0NQH
UK Market
0NQH
RHON-KLINIKUM AG
RESEARCH TOOLSreports

RHON-KLINIKUM AG (0NQH) Ratios

0 Followers

RHON-KLINIKUM AG Ratios

GB:0NQH's free cash flow for Q2 2025 was €>-0.01. For the 2025 fiscal year, GB:0NQH's free cash flow was decreased by € and operating cash flow was €0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.60 2.60 2.23 2.35 2.37
Quick Ratio
 2.49 2.49 2.14 2.25 2.25
Cash Ratio
 0.50 0.50 0.69 0.61 0.27
Solvency Ratio
 0.21 0.21 0.20 0.21 0.21
Operating Cash Flow Ratio
 0.00 0.19 0.32 0.32 0.21
Short-Term Operating Cash Flow Coverage
 0.00 15.77 4.00 113.42 7.57
Net Current Asset Value
€ 422.95M€ 422.95M€ 373.60M€ 298.91M€ 235.10M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.07 0.08 0.08 0.09
Debt-to-Equity Ratio
 0.09 0.09 0.12 0.12 0.13
Debt-to-Capital Ratio
 0.08 0.08 0.10 0.11 0.11
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.08 0.10 0.10
Financial Leverage Ratio
 1.38 1.38 1.43 1.41 1.39
Debt Service Coverage Ratio
 14.04 8.55 3.15 23.39 8.24
Interest Coverage Ratio
 12.67 1.46 14.16 10.92 8.81
Debt to Market Cap
 0.14 0.14 0.15 0.21 0.15
Interest Debt Per Share
 1.87 1.87 2.29 2.29 2.42
Net Debt to EBITDA
 -0.43 -0.69 -1.07 -0.48 0.76
Profitability Margins
Gross Profit Margin
15.73%8.67%10.77%11.69%69.12%
EBIT Margin
2.71%0.23%3.74%2.96%2.60%
EBITDA Margin
6.52%3.59%7.66%6.72%7.34%
Operating Profit Margin
2.39%0.23%3.02%2.33%2.50%
Pretax Profit Margin
2.64%2.32%3.52%2.75%2.33%
Net Profit Margin
2.02%1.78%2.72%2.23%1.74%
Continuous Operations Profit Margin
2.13%1.87%2.83%2.32%1.86%
Net Income Per EBT
76.69%76.69%77.13%81.11%74.77%
EBT Per EBIT
110.44%1022.99%116.73%118.14%93.12%
Return on Assets (ROA)
1.89%1.89%2.34%2.19%1.47%
Return on Equity (ROE)
2.63%2.61%3.35%3.09%2.05%
Return on Capital Employed (ROCE)
2.75%0.30%3.32%2.82%2.55%
Return on Invested Capital (ROIC)
2.22%0.24%2.61%2.36%2.03%
Return on Tangible Assets
2.09%2.09%2.58%2.43%1.65%
Earnings Yield
4.15%4.05%4.66%5.78%2.46%
Efficiency Ratios
Receivables Turnover
 3.37 3.82 3.84 4.40 4.11
Payables Turnover
 19.06 23.46 22.42 22.92 6.38
Inventory Turnover
 35.40 43.57 38.01 44.77 13.40
Fixed Asset Turnover
 2.27 2.58 2.09 2.19 1.76
Asset Turnover
 0.94 1.06 0.86 0.98 0.85
Working Capital Turnover Ratio
 3.14 3.69 3.35 4.08 3.93
Cash Conversion Cycle
 99.55 88.27 88.28 75.27 58.81
Days of Sales Outstanding
 108.39 95.46 94.95 83.04 88.78
Days of Inventory Outstanding
 10.31 8.38 9.60 8.15 27.23
Days of Payables Outstanding
 19.15 15.56 16.28 15.93 57.20
Operating Cycle
 118.70 103.83 104.56 91.20 116.01
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 0.96 1.91 1.63 0.90
Free Cash Flow Per Share
 0.00 -0.52 0.85 0.69 -0.25
CapEx Per Share
 0.00 1.48 1.05 0.94 0.87
Free Cash Flow to Operating Cash Flow
 0.00 -0.54 0.45 0.42 -0.28
Dividend Paid and CapEx Coverage Ratio
 0.00 0.61 1.81 1.50 1.04
Capital Expenditure Coverage Ratio
 0.00 0.65 1.81 1.74 1.04
Operating Cash Flow Coverage Ratio
 0.00 0.53 0.85 0.73 0.38
Operating Cash Flow to Sales Ratio
 0.00 0.03 0.08 0.06 0.04
Free Cash Flow Yield
0.00%-4.07%6.15%6.90%-1.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.08 24.66 21.46 17.29 40.73
Price-to-Sales (P/S) Ratio
 0.49 0.44 0.58 0.39 0.71
Price-to-Book (P/B) Ratio
 0.63 0.64 0.72 0.53 0.84
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -24.57 16.27 14.49 -60.60
Price-to-Operating Cash Flow Ratio
 0.00 13.18 7.29 6.14 16.98
Price-to-Earnings Growth (PEG) Ratio
 -2.75 -1.23 1.78 0.33 -4.28
Price-to-Fair Value
 0.63 0.64 0.72 0.53 0.84
Enterprise Value Multiple
 7.04 11.56 6.55 5.26 10.41
Enterprise Value
 781.95M 802.03M 800.17M 613.17M 1.11B
EV to EBITDA
 7.04 11.56 6.55 5.26 10.41
EV to Sales
 0.46 0.41 0.50 0.35 0.76
EV to Free Cash Flow
 0.00 -23.18 13.99 13.27 -65.39
EV to Operating Cash Flow
 0.00 12.43 6.27 5.63 18.33
Tangible Book Value Per Share
 17.68 17.68 17.21 16.50 16.02
Shareholders’ Equity Per Share
 19.73 19.73 19.36 18.70 18.28
Tax and Other Ratios
Effective Tax Rate
 0.19 0.19 0.20 0.16 0.20
Revenue Per Share
 25.47 28.92 23.84 25.92 21.60
Net Income Per Share
 0.51 0.51 0.65 0.58 0.38
Tax Burden
 0.77 0.77 0.77 0.81 0.75
Interest Burden
 0.97 10.23 0.94 0.93 0.89
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.03 0.08 0.04 0.04 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.87 2.82 2.82 2.40
Currency in EUR